Vilco Pharma Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.31 M
- Company Age 51 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.31 Cr
- Satisfied Charges ₹ 46.70 Cr
- Revenue Growth -75.53%
- Profit Growth 4.08%
- Ebitda 28.31%
- Net Worth -28.02%
- Total Assets -4.90%
About Vilco Pharma
Vilco Pharma Private Limited (VPPL) was founded in India on 26 December 1973 and has a glorious history of 51 years and two months.Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.31 M.
The company currently has active open charges totaling ₹5.31 Cr. The company has closed loans amounting to ₹46.70 Cr, as per Ministry of Corporate Affairs (MCA) records.
Milan Mehta and Pritul Sanghavi serve as directors at the Company.
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24239MH1973PTC017094
- Company No.
017094
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Dec 1973
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Vilco Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Milan Mehta  | Director | 01-Nov-2016 | Current |
| Pritul Sanghavi | Additional Director | 10-Mar-2021 | Current |
Financial Performance of Vilco Pharma.
Vilco Pharma Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 75.53% decrease. The company also saw a slight improvement in profitability, with a 4.08% increase in profit. The company's net worth observed a substantial decline by a decrease of 28.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vilco Pharma?
In 2023, Vilco Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Anakin Management Consultants Pvt.Ltd.Pritul Sanghavi is a mutual person
Anakin Asset Holding LlpMilan Mehta and Pritul Sanghavi are mutual person
- Anakin Real Estate Private Limited
Pritul Sanghavi is a mutual person
Charges (Loans)
₹53.15 M
₹466.98 M
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 4.99 Cr
- The North Kanara Gsb Co-Op Bank Ltd. : 0.20 Cr
- State Bank Of India : 0.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Jan 2021 | Axis Bank Limited | ₹4.99 Cr | Open |
| 24 Jan 2001 | The North Kanara Gsb Co-Op Bank Ltd. | ₹1.98 M | Open |
| 22 Sep 1978 | State Bank Of India | ₹0.57 M | Open |
| 22 Sep 1978 | State Bank Of India | ₹0.57 M | Open |
| 07 Dec 1976 | State Bank Of India | ₹0.12 M | Open |
How Many Employees Work at Vilco Pharma?
Unlock and access historical data on people associated with Vilco Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vilco Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vilco Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
